Thursday, August 27, 2020

Teva faces generics price-fixing charges


The Department of Justice has charged Teva Pharmaceutical Industries with three counts of conspiring with other pharmaceutical firms to inflate the prices of widely used generic drugs, including the cholesterol-lowering medication pravastatin. Teva denied the allegations and said it "will vigorously defend the Company in court."

Full Story: Reuters (8/25) 

No comments:

Post a Comment